The Global Aminoguanidine Hydrochloride Market was valued at US$ 18.5 Million in 2022 and is projected to reach US$ 30.2 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period (2023–2029). This growth is being driven by expanding applications in pharmaceutical intermediates for drug synthesis, increasing veterinary medicine production, and rising demand from research laboratories for high-purity chemicals. Factors such as advancements in organic synthesis techniques and the push for more efficient chemical processes have further fueled this expansion, particularly in emerging markets where healthcare infrastructure is rapidly developing.

As the chemical manufacturing sector shifts toward sustainable and high-precision production, attention turns to the pivotal players who are enhancing purity standards, innovating synthesis methods, and meeting the stringent requirements of pharmaceutical and veterinary industries. In this blog, we profile the Top 10 Companies in the Aminoguanidine Hydrochloride Industry—a combination of specialized Japanese producers, leading Chinese manufacturers, and international suppliers who are at the forefront of delivering reliable, high-quality aminoguanidine hydrochloride for global applications.

---

🔟 1. Sigma-Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Aminoguanidine Hydrochloride (Purity 98%, 99%)

Sigma-Aldrich, now part of Merck KGaA, stands as a global leader in laboratory chemicals and fine chemicals, providing aminoguanidine hydrochloride to research institutions, pharmaceutical companies, and industrial labs worldwide. With a vast distribution network, the company ensures consistent supply of this versatile compound, which serves as a critical intermediate in synthesizing drugs for diabetes management and anti-inflammatory treatments. Their focus on quality control and traceability has made them a preferred choice for customers seeking reliable reagents in sensitive applications.

Beyond standard offerings, Sigma-Aldrich invests heavily in R&D to improve the stability and purity of aminoguanidine hydrochloride, adapting to evolving regulatory standards in the EU and US. This compound’s role in inhibiting advanced glycation end-products (AGEs) has gained traction in biomedical research, and the company supports this through customized formulations and technical support services.

Innovation Initiatives:

• Development of greener synthesis routes to reduce environmental impact

• Partnerships with pharmaceutical firms for custom intermediate production

• Commitment to ISO-certified quality standards and sustainability goals by 2030

Download FREE Sample Report: Aminoguanidine Hydrochloride Market – View in Detailed Research Report

---

9️⃣ 2. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: Aminoguanidine Hydrochloride (Purity 98% and above)

Tokyo Chemical Industry, a prominent Japanese chemical supplier, excels in producing high-purity aminoguanidine hydrochloride for organic synthesis and analytical purposes. Operating across Asia and beyond, TCI caters to academic research and industrial clients who rely on this compound for creating hydrazone derivatives and metal chelators in pharmaceutical development. Their emphasis on precision manufacturing ensures minimal impurities, which is crucial for downstream applications in drug discovery.

TCI’s growth in this market stems from Japan’s advanced chemical engineering capabilities, allowing them to respond quickly to customer needs. The company has expanded its portfolio to include bulk quantities for veterinary drug intermediates, supporting the treatment of various animal health issues. Furthermore, their integration of digital tools for supply chain management has improved delivery times to global markets.

Innovation Initiatives:

• Investment in automated synthesis to enhance production efficiency

• Collaborations with universities for novel applications in biotechnology

---

8️⃣ 3. Acros Organics (Thermo Fisher Scientific)

Headquarters: Geel, Belgium
Key Offering: Aminoguanidine Hydrochloride (Purity 99%)

Acros Organics, under Thermo Fisher Scientific, is renowned for its fine chemicals division, where aminoguanidine hydrochloride plays a key role in supplying pharmaceutical and research sectors across Europe and North America. This compound’s use as a reagent in carbonyl group protection and in the synthesis of biguanides for anti-malarial drugs highlights the company’s contribution to medicinal chemistry. With state-of-the-art facilities, Acros ensures compliance with REACH regulations, making their products trusted in regulatory-heavy markets.

The company’s strategic acquisitions have bolstered its capacity to produce specialized intermediates, addressing the growing need for aminoguanidine hydrochloride in veterinary formulations aimed at poultry and livestock health. By focusing on scalable production, Acros meets the demands of both small-scale R&D and large-volume manufacturing, fostering long-term partnerships with key industry players.

Innovation Initiatives:

• Targets for reducing solvent use in synthesis processes

• Expansion of SAF-like sustainable chemical practices

• Supply agreements with major pharma companies for stable sourcing

---

7️⃣ 4. Nippon Carbide Industries (NCI)

Headquarters: Utsunomiya, Japan
Key Offering: Aminoguanidine Hydrochloride (Purity 98%, 99%)

Nippon Carbide Industries is a cornerstone in Japan’s chemical landscape, specializing in industrial chemicals including aminoguanidine hydrochloride for pharmaceutical intermediates. As one of the earliest producers, NCI supplies this compound to global drug manufacturers for use in synthesizing nitric oxide modulators and anti-diabetic agents. Their rigorous testing protocols guarantee high reactivity and stability, essential for complex synthesis reactions.

With a history spanning decades, NCI has adapted to market shifts by investing in facility upgrades that enhance yield and purity. The company’s presence in Asia-Pacific allows it to serve the burgeoning pharmaceutical hubs in India and China, where demand for veterinary intermediates is surging due to population growth and animal health initiatives. Moreover, NCI’s focus on cost-effective production without compromising quality positions it strongly against competitors.

Innovation Initiatives:

• Goal to increase sustainable raw material sourcing by 20% by 2025

• R&D into bio-based alternatives for traditional synthesis

Download FREE Sample Report: Aminoguanidine Hydrochloride Market – View in Detailed Research Report

---

6️⃣ 5. Wuwei Hailun New Material

Headquarters: Wuwei, Gansu, China
Key Offering: Aminoguanidine Hydrochloride (Purity 98% and 99%)

Wuwei Hailun New Material emerges as a dynamic player in China’s chemical sector, focusing on fine chemicals like aminoguanidine hydrochloride for export to pharmaceutical and veterinary markets. This company leverages local resources to produce cost-competitive products, serving as an intermediate in the manufacture of anti-hypertensive drugs and animal feed additives. Their expansion into international trade has been marked by certifications that meet global standards.

Hailun’s approach involves vertical integration, from raw material sourcing to final packaging, which minimizes costs and ensures supply reliability. As China’s pharmaceutical industry grows, Hailun contributes by supplying high-volume batches, supporting innovations in veterinary drugs for disease prevention in agriculture. Their commitment to worker safety and environmental monitoring aligns with national regulations, building trust among overseas buyers.

Innovation Initiatives:

• Implementation of energy-efficient production lines

• Participation in local innovation programs for chemical purity enhancement

---

5️⃣ 6. Ningxia TianCheng Bio-Chem

Headquarters: Yinchuan, Ningxia, China
Key Offering: Aminoguanidine Hydrochloride (Purity 99%)

Ningxia TianCheng Bio-Chem specializes in biochemical products, with aminoguanidine hydrochloride as a flagship offering for pharmaceutical synthesis and research. Based in the resource-rich Ningxia region, the company supplies this compound to labs developing treatments for metabolic disorders and to veterinary firms creating parasite control agents. Their products are noted for consistent batch quality, which is vital for reproducible experimental results.

TianCheng’s market position strengthens through strategic exports to Europe and the US, where demand for high-purity intermediates is high. The company has invested in analytical equipment to verify purity levels, addressing customer concerns about contaminants. Furthermore, their role in supporting China’s bio-economy includes collaborations on sustainable chemical pathways, reducing reliance on non-renewable inputs.

Innovation Initiatives:

• Current production capacity exceeding 500 tons annually

• Aim to double output with eco-friendly technologies by 2027

Download FREE Sample Report: Aminoguanidine Hydrochloride Market – View in Detailed Research Report

---

4️⃣ 7. Shanxi Zhichen Chemical

Headquarters: Taiyuan, Shanxi, China
Key Offering: Aminoguanidine Hydrochloride (Purity 98%)

Shanxi Zhichen Chemical is a dedicated producer of organic chemicals, including aminoguanidine hydrochloride used extensively in pharmaceutical intermediates for cardiovascular drugs. Operating in China’s industrial heartland, Zhichen supplies domestic and international markets, emphasizing affordability without sacrificing efficacy. This compound’s application in forming guanidine derivatives for anti-fungal veterinary products underscores their versatility.

Zhichen’s growth is tied to the region’s chemical clusters, enabling efficient logistics and raw material access. The company has pursued certifications like GMP for pharma-grade materials, opening doors to stricter markets. By focusing on waste minimization and recycling, they contribute to sustainable practices, appealing to environmentally conscious clients globally.

Innovation Initiatives:

• Ongoing R&D for cost-optimized synthesis methods

• Partnerships with regional universities for application expansion

---

3️⃣ 8. Ningxia Sikeda Biotechnology

Headquarters: Shizuishan, Ningxia, China
Key Offering: Aminoguanidine Hydrochloride (Purity 99%)

Ningxia Sikeda Biotechnology combines biotech expertise with chemical manufacturing, producing aminoguanidine hydrochloride for advanced pharmaceutical and veterinary uses. As a key supplier in China, Sikeda supports the synthesis of bioactive molecules for anti-cancer research and animal nutrition supplements. Their biotech angle allows for innovative modifications, enhancing the compound’s bioavailability in end products.

Sikeda’s export-oriented strategy has positioned it well in the Asia-Pacific region, where veterinary drug demand is booming due to livestock intensification. The company’s investment in clean production technologies reflects a commitment to quality and sustainability, aligning with global trends toward greener chemicals. Through rigorous testing, they ensure the compound meets pharmacopeia standards.

Innovation Initiatives:

• Indigenous development of bio-derived synthesis processes

• Collaborations to scale production for emerging markets

---

2️⃣ 9. VWR International (Avantor)

Headquarters: Radnor, Pennsylvania, USA
Key Offering: Aminoguanidine Hydrochloride (Purity 98%, 99%)

VWR International, part of Avantor, is a major distributor and producer of lab chemicals, offering aminoguanidine hydrochloride to North American and European research facilities. This compound supports analytical chemistry and drug development, particularly in histochemistry and enzyme inhibition studies. VWR’s integrated supply chain ensures just-in-time delivery, critical for time-sensitive projects.

With a focus on the US market, VWR addresses the need for compliant materials in FDA-regulated environments. Their expansion into custom synthesis services allows clients to tailor aminoguanidine hydrochloride for specific veterinary applications, such as feed preservatives. Avantor’s broader portfolio in life sciences amplifies VWR’s impact in this niche.

Innovation Initiatives:

• Goals for 100% traceable supply chains by 2028

• Major expansions in renewable chemical sourcing

---

1️⃣ 10. Fisher Scientific (Thermo Fisher Scientific)

Headquarters: Waltham, Massachusetts, USA
Key Offering: Aminoguanidine Hydrochloride (Purity 98% and 99%)

Fisher Scientific, a division of Thermo Fisher, leads in scientific supplies, providing aminoguanidine hydrochloride to labs worldwide for pharmaceutical R&D and quality control. As a top distributor, they support the compound’s use in synthesizing derivatives for anti-viral drugs and veterinary anti-parasitics. Their global reach covers over 150 countries, ensuring accessibility for diverse applications.

Fisher’s strength lies in comprehensive services, from small quantities for research to bulk for production. They have pioneered digital platforms for ordering and tracking, streamlining procurement. In sustainability, Thermo Fisher’s overarching goals include carbon-neutral operations, influencing how Fisher sources and handles chemicals like aminoguanidine hydrochloride.

Innovation Initiatives:

• End-to-end solutions for lab-to-market chemical integration

• Strategic alliances with producers for seamless supply

Get Full Report Here: Aminoguanidine Hydrochloride Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Aminoguanidine Hydrochloride Is Innovative and Sustainable

The aminoguanidine hydrochloride market is experiencing a transformative phase. While traditional synthesis methods remain prevalent, the sector is channeling significant investments into high-purity variants, advanced production technologies, and sustainable manufacturing networks to meet rising demands from pharmaceuticals and veterinary sectors.

This report aims to provide a comprehensive presentation of the global market for Aminoguanidine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoguanidine Hydrochloride. Key metrics include global revenue from 2018-2023 and forecasts to 2030 in millions of USD, sales volumes in tons, and the market share of the top five companies, which accounted for approximately 65% in 2022.

The U.S. market is estimated at $4.2 Million in 2022, while China is forecast to reach $12.5 Million by 2029. The Purity 98% segment is projected to reach $15.8 Million by 2029, with a 6.8% CAGR in the next six years. Leading manufacturers like Nippon Carbide Industries, Wuwei Hailun New Material, Ningxia TianCheng Bio-Chem, Shanxi Zhichen Chemical, and Ningxia Sikeda Biotechnology dominate, with surveys indicating strong demand growth despite challenges like raw material price fluctuations.

Market segmentation by type covers Purity 98% and 99%, with applications in pharmaceutical and veterinary drug intermediates. Regionally, Asia-Pacific leads with over 50% share in 2022, followed by North America and Europe. Competitor analysis highlights revenue shares, with key players driving innovation through mergers and R&D investments.

📈 Key Trends Shaping the Market:

• Rapid expansion of production capacity in Asia-Pacific, particularly China

• Regulatory mandates for higher purity standards in pharmaceutical applications by 2030

• Digitalization of supply chains and quality assurance tracking

• Industry alliances for sustainable synthesis and waste reduction

Get Full Report Here: Aminoguanidine Hydrochloride Market – View in Detailed Research Report

The companies listed above are not only supplying essential intermediates—they’re spearheading the innovation in chemical synthesis for healthier pharmaceuticals and veterinary solutions.